chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Knot at injection site; Injection site itchy and red; Injection site itchy and red; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (Knot at injection site), INJECTION SITE PRURITUS (Injection site itchy and red) and INJECTION SITE ERYTHEMA (Injection site itchy and red) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, the patient experienced INJECTION SITE SWELLING (Knot at injection site), INJECTION SITE PRURITUS (Injection site itchy and red) and INJECTION SITE ERYTHEMA (Injection site itchy and red). At the time of the report, INJECTION SITE SWELLING (Knot at injection site), INJECTION SITE PRURITUS (Injection site itchy and red) and INJECTION SITE ERYTHEMA (Injection site itchy and red) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: pain at the site; itching; pinkish area; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at the site), VACCINATION SITE PRURITUS (itching) and VACCINATION SITE ERYTHEMA (pinkish area) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 19-Jan-2021, the patient experienced VACCINATION SITE PAIN (pain at the site), VACCINATION SITE PRURITUS (itching) and VACCINATION SITE ERYTHEMA (pinkish area). At the time of the report, VACCINATION SITE PAIN (pain at the site) and VACCINATION SITE PRURITUS (itching) outcome was unknown and VACCINATION SITE ERYTHEMA (pinkish area) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Neck pain, Pyrexia, Vaccination site pain
Clinical narrative: Brain fog; pain in the neck; sore arm on injection site; Severe chills; High fever; This spontaneous case was reported by a patient and describes the occurrence of NECK PAIN (pain in the neck), VACCINATION SITE PAIN (sore arm on injection site), CHILLS (Severe chills), PYREXIA (High fever) and FEELING ABNORMAL (Brain fog) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced NECK PAIN (pain in the neck), VACCINATION SITE PAIN (sore arm on injection site), CHILLS (Severe chills) and PYREXIA (High fever). On 23-Jan-2021, the patient experienced FEELING ABNORMAL (Brain fog). At the time of the report, NECK PAIN (pain in the neck), VACCINATION SITE PAIN (sore arm on injection site), CHILLS (Severe chills), PYREXIA (High fever) and FEELING ABNORMAL (Brain fog) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm was a little sore; This spontaneous case was reported by an other and describes the occurrence of PAIN IN EXTREMITY (arm was a little sore) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm was a little sore). At the time of the report, PAIN IN EXTREMITY (arm was a little sore) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications was reported. No treatment information was provided.    Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness). At the time of the report, DIZZINESS (dizziness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Vaccination site erythema, Vaccination site pain
Clinical narrative: Arm sore; Chills; Fatigue; Arm red; Arm  swollen; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm sore), CHILLS (Chills), FATIGUE (Fatigue), VACCINATION SITE ERYTHEMA (Arm red) and VACCINATION SITE SWELLING (Arm  swollen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm sore), CHILLS (Chills), FATIGUE (Fatigue), VACCINATION SITE ERYTHEMA (Arm red), VACCINATION SITE SWELLING (Arm  swollen) and MYALGIA (Body aches). At the time of the report, VACCINATION SITE PAIN (Arm sore), VACCINATION SITE ERYTHEMA (Arm red) and VACCINATION SITE SWELLING (Arm  swollen) was resolving and CHILLS (Chills), FATIGUE (Fatigue) and MYALGIA (Body aches) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.   Reporter did not allow further contact.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Arm sore; Chills; Fatigue; Arm red; Arm  swollen; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm sore), CHILLS (Chills), FATIGUE (Fatigue), VACCINATION SITE ERYTHEMA (Arm red) and VACCINATION SITE SWELLING (Arm  swollen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm sore), CHILLS (Chills), FATIGUE (Fatigue), VACCINATION SITE ERYTHEMA (Arm red), VACCINATION SITE SWELLING (Arm  swollen) and MYALGIA (Body aches). At the time of the report, VACCINATION SITE PAIN (Arm sore), VACCINATION SITE ERYTHEMA (Arm red) and VACCINATION SITE SWELLING (Arm  swollen) was resolving and CHILLS (Chills), FATIGUE (Fatigue) and MYALGIA (Body aches) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.   Reporter did not allow further contact.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: Age related shakes are gone; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Age related shakes are gone) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Age related shakes are gone). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Age related shakes are gone) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  Treatment information was not provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site pain
Clinical narrative: headache; Fatigue; Pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), FATIGUE (Fatigue) and INJECTION SITE PAIN (Pain at the injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history). Concurrent medical conditions included Hypertension (It is reported that the patient is taking blood pressure medications regularly.) and Hyperlipidemia (it is reported that the patient is on cholesterol medications.).    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced HEADACHE (headache), FATIGUE (Fatigue) and INJECTION SITE PAIN (Pain at the injection site). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] (oral) on 24-Jan-2021 for Pain relief, at an unspecified dose and frequency. At the time of the report, HEADACHE (headache), FATIGUE (Fatigue) and INJECTION SITE PAIN (Pain at the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pain in extremity, Vaccination site pain, Vaccination site swelling
Clinical narrative: arm was sore; chills; a little headache; teeth were rattling; injection site had a little bump; a little bit of hurt; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (arm was sore), VACCINATION SITE SWELLING (injection site had a little bump), VACCINATION SITE PAIN (a little bit of hurt), CHILLS (chills) and HEADACHE (a little headache) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE SWELLING (injection site had a little bump) and VACCINATION SITE PAIN (a little bit of hurt). On 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm was sore), CHILLS (chills), HEADACHE (a little headache) and CHILLS (teeth were rattling). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm was sore), VACCINATION SITE SWELLING (injection site had a little bump), VACCINATION SITE PAIN (a little bit of hurt), CHILLS (chills), HEADACHE (a little headache) and CHILLS (teeth were rattling) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Injection site erythema, Rash, Rash macular
Clinical narrative: Rash on right arm above elvow to middle of hand; All red dots and blotchy/spots around her elbow; Blotchy; Little Dizzy; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on right arm above elvow to middle of hand), INJECTION SITE ERYTHEMA (All red dots and blotchy/spots around her elbow), RASH MACULAR (Blotchy) and DIZZINESS (Little Dizzy) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included Autoimmune disorder NOS and Heart disease, unspecified. Concomitant products included PREGABALIN, VITAMINS NOS, COLECALCIFEROL (D3), PROBIOTICS NOS, LEVETIRACETAM, ALPRAZOLAM, SERTRALINE, METOPROLOL SUCCINATE (TOPROL), VERAPAMIL, ZOLPIDEM TARTRATE (AMBIEN) and AZITHROMYCIN for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 25-Jan-2021, the patient experienced RASH (Rash on right arm above elvow to middle of hand), INJECTION SITE ERYTHEMA (All red dots and blotchy/spots around her elbow), RASH MACULAR (Blotchy) and DIZZINESS (Little Dizzy). At the time of the report, RASH (Rash on right arm above elvow to middle of hand), INJECTION SITE ERYTHEMA (All red dots and blotchy/spots around her elbow), RASH MACULAR (Blotchy) and DIZZINESS (Little Dizzy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  No treatment information was provided.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Vaccination site erythema, Vaccination site pain, Vaccination site warmth
Clinical narrative: hot to the touch; arm became sore; red injection site; bad chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot to the touch), CHILLS (bad chills), VACCINATION SITE PAIN (arm became sore) and VACCINATION SITE ERYTHEMA (red injection site) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced CHILLS (bad chills). On 23-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot to the touch), VACCINATION SITE PAIN (arm became sore) and VACCINATION SITE ERYTHEMA (red injection site). At the time of the report, VACCINATION SITE WARMTH (hot to the touch), CHILLS (bad chills), VACCINATION SITE PAIN (arm became sore) and VACCINATION SITE ERYTHEMA (red injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  Treatment information was not provided.  It was reported that the patient's symptoms were continuing.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: NNI: Patient's email address has been updated.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Joint pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of ARTHRALGIA (Joint pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Joint pain). At the time of the report, ARTHRALGIA (Joint pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Non-significant information received (consumer's email).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: sore arm; very fatigued; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and FATIGUE (very fatigued) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     Concurrent medical conditions included Cancer (Patient goes for Chemotherapy every 27 or 28 days, also takes a chemo pill daily. ).    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 21-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and FATIGUE (very fatigued). At the time of the report, PAIN IN EXTREMITY (sore arm) and FATIGUE (very fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Vaccination site pain
Clinical narrative: Entire arm was achy; Achiness had localized to just around the injection site; Mild headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Entire arm was achy), VACCINATION SITE PAIN (Achiness had localized to just around the injection site) and HEADACHE (Mild headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Entire arm was achy), VACCINATION SITE PAIN (Achiness had localized to just around the injection site) and HEADACHE (Mild headache). At the time of the report, PAIN IN EXTREMITY (Entire arm was achy) and VACCINATION SITE PAIN (Achiness had localized to just around the injection site) outcome was unknown and HEADACHE (Mild headache) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications and treatment details were provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site discolouration, Vaccination site induration, Vaccination site pruritus
Clinical narrative: 6 inches circle around the injection site; big hard lump; itchy; much more tired; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE DISCOLOURATION (6 inches circle around the injection site) and VACCINATION SITE INDURATION (big hard lump) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), SIMVASTATIN, EZETIMIBE and HYDROCHLOROTHIAZIDE, TELMISARTAN (TELMISARTAN HCTZ) for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE DISCOLOURATION (6 inches circle around the injection site) and VACCINATION SITE INDURATION (big hard lump). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, INJECTION SITE DISCOLOURATION (6 inches circle around the injection site) had not resolved and VACCINATION SITE INDURATION (big hard lump) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Reporter's Comments: This case concerns a 77-year-old female who had a non-serious unexpected event of injection site mass and non-serious expected events of vaccination site pruritus, injection site discoloration, and fatigue.  The events occurred about one week after the first dose of mRNA-1273. Treated with Benadryl. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (soreness at the injection site) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced ARTHRALGIA (soreness at the injection site). At the time of the report, ARTHRALGIA (soreness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case concerns an 88-year-old female who experienced a nonserious expected event of arthralgia. The event occurred the same day as the first dose of mRNA-1273. Treatment included Tylenol. Event outcome unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: This case concerns an 88-year-old female who experienced a nonserious expected event of arthralgia. The event occurred the same day as the first dose of mRNA-1273. Treatment included Tylenol. Event outcome unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Nausea, Pyrexia, Vomiting
Clinical narrative: short of breath; nausea; throwing up; temperature was varying 97-99; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (short of breath), NAUSEA (nausea), VOMITING (throwing up) and PYREXIA (temperature was varying 97-99) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event reported).    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DYSPNOEA (short of breath), NAUSEA (nausea), VOMITING (throwing up) and PYREXIA (temperature was varying 97-99). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, DYSPNOEA (short of breath), NAUSEA (nausea), VOMITING (throwing up) and PYREXIA (temperature was varying 97-99) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Nausea, Vomiting
Clinical narrative: Nausea; Vomiting; pain in the joints of her legs; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), VOMITING (Vomiting) and ARTHRALGIA (pain in the joints of her legs) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2021, the patient experienced NAUSEA (Nausea), VOMITING (Vomiting) and ARTHRALGIA (pain in the joints of her legs). At the time of the report, NAUSEA (Nausea), VOMITING (Vomiting) and ARTHRALGIA (pain in the joints of her legs) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications and treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: No new information . Patient said that she is doing great.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dehydration, Dry mouth, Pyrexia, Vaccination complication
Clinical narrative: dehydration; cotton mouth; felt weak; fever; chills; warm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm at the injection site), DEHYDRATION (dehydration), DRY MOUTH (cotton mouth), VACCINATION COMPLICATION (felt weak) and PYREXIA (fever) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 23-Jan-2021, the patient experienced VACCINATION SITE WARMTH (warm at the injection site), PYREXIA (fever) and CHILLS (chills).   On 24-Jan-2021, the patient experienced DEHYDRATION (dehydration), DRY MOUTH (cotton mouth) and VACCINATION COMPLICATION (felt weak).   On 24-Jan-2021, VACCINATION SITE WARMTH (warm at the injection site), DEHYDRATION (dehydration), DRY MOUTH (cotton mouth), PYREXIA (fever) and CHILLS (chills) had resolved. On 25-Jan-2021, VACCINATION COMPLICATION (felt weak) had resolved.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: dehydration; cotton mouth; felt weak; fever; chills; warm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm at the injection site), DEHYDRATION (dehydration), DRY MOUTH (cotton mouth), VACCINATION COMPLICATION (felt weak) and PYREXIA (fever) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 23-Jan-2021, the patient experienced VACCINATION SITE WARMTH (warm at the injection site), PYREXIA (fever) and CHILLS (chills).   On 24-Jan-2021, the patient experienced DEHYDRATION (dehydration), DRY MOUTH (cotton mouth) and VACCINATION COMPLICATION (felt weak).   On 24-Jan-2021, VACCINATION SITE WARMTH (warm at the injection site), DEHYDRATION (dehydration), DRY MOUTH (cotton mouth), PYREXIA (fever) and CHILLS (chills) had resolved. On 25-Jan-2021, VACCINATION COMPLICATION (felt weak) had resolved.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No relevant concomitant medications were reported.    Treatment information was not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Nausea, Pyrexia, Vaccination site movement impairment
Clinical narrative: diarrhea; could not move the arm where the vaccine was administered; headaches; nausea; fever of 103-104.1°F; arm where the vaccine was administered was swollen; This spontaneous case was reported by a patient and describes the occurrence of DIARRHOEA (diarrhea), VACCINATION SITE MOVEMENT IMPAIRMENT (could not move the arm where the vaccine was administered), HEADACHE (headaches), NAUSEA (nausea) and PYREXIA (fever of 103-104.1°F) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 23-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to dosage form. On 24-Jan-2021, the patient experienced DIARRHOEA (diarrhea), VACCINATION SITE MOVEMENT IMPAIRMENT (could not move the arm where the vaccine was administered), HEADACHE (headaches), NAUSEA (nausea), PYREXIA (fever of 103-104.1°F) and VACCINATION SITE SWELLING (arm where the vaccine was administered was swollen). At the time of the report, DIARRHOEA (diarrhea), VACCINATION SITE MOVEMENT IMPAIRMENT (could not move the arm where the vaccine was administered), HEADACHE (headaches), NAUSEA (nausea), PYREXIA (fever of 103-104.1°F) and VACCINATION SITE SWELLING (arm where the vaccine was administered was swollen) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    No relevant Concomitant medications  were provided.  Treatment was not provided. Action taken with mRNA-1273 in response to the events was not applicable..
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: diarrhea; could not move the arm where the vaccine was administered; headaches; nausea; fever of 103-104.1°F; arm where the vaccine was administered was swollen; This spontaneous case was reported by a patient and describes the occurrence of DIARRHOEA (diarrhea), VACCINATION SITE MOVEMENT IMPAIRMENT (could not move the arm where the vaccine was administered), HEADACHE (headaches), NAUSEA (nausea) and PYREXIA (fever of 103-104.1°F) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 23-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to dosage form. On 24-Jan-2021, the patient experienced DIARRHOEA (diarrhea), VACCINATION SITE MOVEMENT IMPAIRMENT (could not move the arm where the vaccine was administered), HEADACHE (headaches), NAUSEA (nausea), PYREXIA (fever of 103-104.1°F) and VACCINATION SITE SWELLING (arm where the vaccine was administered was swollen). At the time of the report, DIARRHOEA (diarrhea), VACCINATION SITE MOVEMENT IMPAIRMENT (could not move the arm where the vaccine was administered), HEADACHE (headaches), NAUSEA (nausea), PYREXIA (fever of 103-104.1°F) and VACCINATION SITE SWELLING (arm where the vaccine was administered was swollen) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    No relevant Concomitant medications  were provided.  Treatment was not provided. Action taken with mRNA-1273 in response to the events was not applicable..
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature abnormal, Chills, Dizziness, Fatigue, Headache
Clinical narrative: a lot of pain in my arm; couldn't regular body temperature; pounding headache; fever of 99.6 F; chills; light-headed; as soon as my head hit the pillow, I fell asleep/felt like I had just taken a Benadryl; Tired; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (light-headed), PAIN IN EXTREMITY (a lot of pain in my arm), BODY TEMPERATURE ABNORMAL (couldn't regular body temperature), SOMNOLENCE (as soon as my head hit the pillow, I fell asleep/felt like I had just taken a Benadryl) and FATIGUE (Tired) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 21-Jan-2021, the patient experienced DIZZINESS (light-headed), SOMNOLENCE (as soon as my head hit the pillow, I fell asleep/felt like I had just taken a Benadryl) and FATIGUE (Tired).   On 22-Jan-2021, the patient experienced PAIN IN EXTREMITY (a lot of pain in my arm), BODY TEMPERATURE ABNORMAL (couldn't regular body temperature), HEADACHE (pounding headache), PYREXIA (fever of 99.6 F) and CHILLS (chills). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) on 21-Jan-2021 at an unspecified dose and frequency.   On 24-Jan-2021, DIZZINESS (light-headed), PAIN IN EXTREMITY (a lot of pain in my arm), BODY TEMPERATURE ABNORMAL (couldn't regular body temperature), SOMNOLENCE (as soon as my head hit the pillow, I fell asleep/felt like I had just taken a Benadryl) and HEADACHE (pounding headache) had resolved. At the time of the report, FATIGUE (Tired), PYREXIA (fever of 99.6 F) and CHILLS (chills) had resolved.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No concomitant medications reported.   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: No significant information received. Updated reporter's email address.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Somnolence
Clinical narrative: a lot of pain in my arm; couldn't regular body temperature; pounding headache; fever of 99.6 F; chills; light-headed; as soon as my head hit the pillow, I fell asleep/felt like I had just taken a Benadryl; Tired; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (light-headed), PAIN IN EXTREMITY (a lot of pain in my arm), BODY TEMPERATURE ABNORMAL (couldn't regular body temperature), SOMNOLENCE (as soon as my head hit the pillow, I fell asleep/felt like I had just taken a Benadryl) and FATIGUE (Tired) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 21-Jan-2021, the patient experienced DIZZINESS (light-headed), SOMNOLENCE (as soon as my head hit the pillow, I fell asleep/felt like I had just taken a Benadryl) and FATIGUE (Tired).   On 22-Jan-2021, the patient experienced PAIN IN EXTREMITY (a lot of pain in my arm), BODY TEMPERATURE ABNORMAL (couldn't regular body temperature), HEADACHE (pounding headache), PYREXIA (fever of 99.6 F) and CHILLS (chills). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) on 21-Jan-2021 at an unspecified dose and frequency.   On 24-Jan-2021, DIZZINESS (light-headed), PAIN IN EXTREMITY (a lot of pain in my arm), BODY TEMPERATURE ABNORMAL (couldn't regular body temperature), SOMNOLENCE (as soon as my head hit the pillow, I fell asleep/felt like I had just taken a Benadryl) and HEADACHE (pounding headache) had resolved. At the time of the report, FATIGUE (Tired), PYREXIA (fever of 99.6 F) and CHILLS (chills) had resolved.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No concomitant medications reported.   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: No significant information received. Updated reporter's email address.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: Severe pain in the arm; soreness in the upper arm; soreness in the shoulder; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Severe pain in the arm; soreness in the upper arm) and ARTHRALGIA (soreness in the shoulder) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (Severe pain in the arm; soreness in the upper arm) and ARTHRALGIA (soreness in the shoulder). At the time of the report, PAIN IN EXTREMITY (Severe pain in the arm; soreness in the upper arm) and ARTHRALGIA (soreness in the shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient reported no concomitant product use. No treatment was administered for the events.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site rash
Clinical narrative: rash on the arm at the site where the vaccination was given; injection site redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash on the arm at the site where the vaccination was given) and VACCINATION SITE ERYTHEMA (injection site redness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (rash on the arm at the site where the vaccination was given) and VACCINATION SITE ERYTHEMA (injection site redness). At the time of the report, VACCINATION SITE RASH (rash on the arm at the site where the vaccination was given) and VACCINATION SITE ERYTHEMA (injection site redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Pain in extremity, Vaccination site erythema, Vaccination site induration, Vaccination site irritation
Clinical narrative: Injection site felt like a lump; Allergic reaction. It became pretty large.; Hardness at the injection site; Injection site is itchy; Redness; Irritated; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE IRRITATION (Irritated), PAIN IN EXTREMITY (sore arm), VACCINATION SITE MASS (Injection site felt like a lump), HYPERSENSITIVITY (Allergic reaction. It became pretty large.) and VACCINATION SITE INDURATION (Hardness at the injection site) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On an unknown date, the patient experienced VACCINATION SITE IRRITATION (Irritated), VACCINATION SITE MASS (Injection site felt like a lump), HYPERSENSITIVITY (Allergic reaction. It became pretty large.), VACCINATION SITE INDURATION (Hardness at the injection site), VACCINATION SITE PRURITUS (Injection site is itchy) and VACCINATION SITE ERYTHEMA (Redness). On 16-Jan-2021, PAIN IN EXTREMITY (sore arm) had resolved. At the time of the report, VACCINATION SITE IRRITATION (Irritated), VACCINATION SITE MASS (Injection site felt like a lump), HYPERSENSITIVITY (Allergic reaction. It became pretty large.), VACCINATION SITE INDURATION (Hardness at the injection site), VACCINATION SITE PRURITUS (Injection site is itchy) and VACCINATION SITE ERYTHEMA (Redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: Telephone Contact Report (TCR) was obtained on 14-APR-2021 contains no new information. On 08-Jun-2021: Follow up was received on 08-JUN-2021 found to be non-significant and Contact information was updated.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass, Vaccination site pruritus
Clinical narrative: Injection site felt like a lump; Allergic reaction. It became pretty large.; Hardness at the injection site; Injection site is itchy; Redness; Irritated; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE IRRITATION (Irritated), PAIN IN EXTREMITY (sore arm), VACCINATION SITE MASS (Injection site felt like a lump), HYPERSENSITIVITY (Allergic reaction. It became pretty large.) and VACCINATION SITE INDURATION (Hardness at the injection site) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On an unknown date, the patient experienced VACCINATION SITE IRRITATION (Irritated), VACCINATION SITE MASS (Injection site felt like a lump), HYPERSENSITIVITY (Allergic reaction. It became pretty large.), VACCINATION SITE INDURATION (Hardness at the injection site), VACCINATION SITE PRURITUS (Injection site is itchy) and VACCINATION SITE ERYTHEMA (Redness). On 16-Jan-2021, PAIN IN EXTREMITY (sore arm) had resolved. At the time of the report, VACCINATION SITE IRRITATION (Irritated), VACCINATION SITE MASS (Injection site felt like a lump), HYPERSENSITIVITY (Allergic reaction. It became pretty large.), VACCINATION SITE INDURATION (Hardness at the injection site), VACCINATION SITE PRURITUS (Injection site is itchy) and VACCINATION SITE ERYTHEMA (Redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: Telephone Contact Report (TCR) was obtained on 14-APR-2021 contains no new information. On 08-Jun-2021: Follow up was received on 08-JUN-2021 found to be non-significant and Contact information was updated.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Pyrexia
Clinical narrative: Felt sick; Fever; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt sick) and PYREXIA (Fever) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (Felt sick) and PYREXIA (Fever). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, MALAISE (Felt sick) and PYREXIA (Fever) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration
Clinical narrative: Redness at the injection site; Induration at the injection site; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE INDURATION (Induration at the injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE INDURATION (Induration at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE INDURATION (Induration at the injection site) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 18-Feb-2021: Outcome of events updated.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling, Pruritus
Clinical narrative: Big swelling on right arm; Itched like crazy; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Big swelling on right arm) and PRURITUS (Itched like crazy) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On an unknown date, the patient experienced PERIPHERAL SWELLING (Big swelling on right arm) and PRURITUS (Itched like crazy).   At the time of the report, PERIPHERAL SWELLING (Big swelling on right arm) and PRURITUS (Itched like crazy) was resolving.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.